OOIR: Observatory of International Research

Papers

(The H4-Index of npj Precision Oncology is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)	240
Improved prediction of MAPKi response duration in melanoma patients using genomic data and machine learning	118
Author Correction: An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	113
Patient-level proteomic network prediction by explainable artificial intelligence	102
Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood	101
Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs	100
Genome-wide analyses reveals an association between invasive urothelial carcinoma in the Shetland sheepdog and NIPAL1	98
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP	95
Sub-regional radiomics combining multichannel 2-dimensional or 3-dimensional deep learning for predicting neoadjuvant chemo-immunotherapy response in esophageal squamous cell carcinoma: a multicenter	90
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada	77
Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis	76
Circulating tumor DNA in ALK-positive anaplastic large cell lymphoma: a proof-of-concept study	66
Constitutional mismatch repair deficiency mimicking Lynch syndrome is associated with hypomorphic mismatch repair gene variants	65
The dynamic immune behavior of primary and metastatic ovarian carcinoma	58
Mucin-1: a promising pan-cancer therapeutic target	57
BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study	55
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes	53
Interferon signaling and ferroptosis in tumor immunology and therapy	53
Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers	53
An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	50
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates	50
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3	50
Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies	49
Development and testing of a polygenic risk score for breast cancer aggressiveness	48
Barriers and opportunities in pancreatic cancer immunotherapy	47

Enhanced efficacy of ipilimumab plus nivolumab in angiogenic subtypes of metastatic clear-cell renal cell carcinoma	47
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma	47
Erigoster B targeting DECR1 induces ferroptosis of breast cancer cells via promoting phosphatidylcholine/arachidonic acid metabolism	46
Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer	44
TRIM65 regulates glucose metabolic reprogramming to promote glioma cell proliferation via ubiquitination and degradation of AMPK	43
Machine learning model for predicting tertiary lymphoid structures and treatment response in triple-negative breast cancer	41
A universal immunohistochemistry analyzer for generalizing AI-driven assessment of immunohistochemistry across immunostains and cancer types	41
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading	41
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab	40
Establishing predictive machine learning models for drug responses in patient derived cell culture	40
Discovery of prognostic lncRNAs in colorectal cancer using spatial transcriptomics	39
First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound	39
Single-cell landscape of bronchoalveolar immune cells in patients with immune checkpoint inhibitor-related pneumonitis	38